Loading asset research
Oramed Pharmaceuticals Inc. Common Stock
ORMPNasdaq · USD · StocksQuote as of · Exchange session not verified$4.66
-2.10%
Today
ORMP
Loading 1D prices…
Market cap
$193.8M
Volume
144.5K
52w high
$5.4752w low
$1.95Company profile
Oramed Pharmaceuticals Inc. Common Stock
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes. The company has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York, New York.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
New York, NY, United States
Fiscal year end
1231
CIK
1176309
Session & valuation
Open$4.81
Previous close$4.76
Day high$4.82
Day low$4.65
30-day avg. volume216.4K
Outstanding shares41.6M
Diluted EPS$1.50
Latest annual period
P/E (trailing)1.13
P/E (forward)-58.25
Price / book0.61
Beta1.19
Dividend yield+5.36%
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| ORGOOrganogenesis Holdings Inc. Class A Common Stock | $191.7M | $564.2M | +6.56% | $0.15 | -2.94% | Hold |
| NERVMinerva Neurosciences Inc Common Stock | $198.2M | $0.00 | — | -$34.67 | -0.24% | Hold |
| KRROKorro Bio Inc. Common Stock | $203.4M | $6.4M | -1834.48% | -$12.48 | +5.74% | Buy |
| TNXPTonix Pharmaceuticals Holding Corp. Common Stock | $203.6M | $13.1M | -946.22% | -$14.57 | -3.34% | Buy |
| DERMJourney Medical Corporation Common Stock | $204.1M | $61.2M | -18.67% | -$0.47 | +2.12% | Buy |